Regulation of lipid and lipoprotein metabolism by PPAR activators.
about
Loss of the acyl-CoA binding protein (Acbp) results in fatty acid metabolism abnormalities in mouse hair and skinClofibrate causes an upregulation of PPAR-{alpha} target genes but does not alter expression of SREBP target genes in liver and adipose tissue of pigs.Hyper- and hypo- nutrition studies of the hepatic transcriptome and epigenome suggest that PPARα regulates anaerobic glycolysisEffects of dietary inclusion of high concentrations of crude glycerin on meat quality and fatty acid profile of feedlot fed Nellore bullsLipid-lowering drugs in lupus: an unexplored therapeutic intervention.A comparative study of genome-wide transcriptional profiles of primary hepatocytes in collagen sandwich and monolayer cultures.The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity.Smoking diminishes the beneficial effect of statins: observations from the landmark trials.Pathophysiology of dyslipidaemia in the metabolic syndrome.Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer.Hepatic Cerebroside Sulfotransferase Is Induced by PPARα Activation in MiceQuercetin Protects against Cadmium-Induced Renal Uric Acid Transport System Alteration and Lipid Metabolism Disorder in Rats.Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy.Increase of palmitic acid concentration impairs endothelial progenitor cell and bone marrow-derived progenitor cell bioavailability: role of the STAT5/PPARγ transcriptional complex.Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-IAll-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor.Demographic, Reproductive, and Dietary Determinants of Perfluorooctane Sulfonic (PFOS) and Perfluorooctanoic Acid (PFOA) Concentrations in Human ColostrumPharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish.Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus.Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulinPharmaceuticals and personal care products: A critical review of the impacts on fish reproduction.Proteomic analysis reveals the enhancement of human serum apolipoprotein A-1(APO A-1) in individuals infected with multiple dengue virus serotypes.Fenofibrate, a peroxisome proliferator-activated receptor α-agonist, blocks lipopolysaccharide-induced inflammatory pathways in mouse liver.Antagonism of the actions of peroxisome proliferator-activated receptor-alpha by bile acids.Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta.Peroxisome proliferator-activated receptors in HCV-related infectionEvaluation of the role of peroxisome-proliferator-activated receptor alpha in the regulation of cardiac pyruvate dehydrogenase kinase 4 protein expression in response to starvation, high-fat feeding and hyperthyroidism.Fatty Acid Accumulation and Resulting PPARα Activation in Fibroblasts due to Trifunctional Protein Deficiency.Design of a chimeric promoter induced by pro-inflammatory mediators in articular chondrocytes.Exposure to 4100K fluorescent light elicits sex specific transcriptional responses in Xiphophorus maculatus skin.Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals.Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice.Anti-obesity and hypolipidemic effects of Fuzhuan brick tea water extract in high-fat diet-induced obese rats.Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate.Salacia - The new multi-targeted approach in diabetics.Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.Transcriptional Regulation of T-Cell Lipid Metabolism: Implications for Plasma Membrane Lipid Rafts and T-Cell Function.Differential characterization of myogenic satellite cells with linolenic and retinoic acid in the presence of thiazolidinediones from prepubertal Korean black goats.Non-classical Transcriptional Activity of Retinoic Acid.Lipid metabolism and lipophagy in cancer.
P2860
Q28588458-2D15055A-3B88-497D-BFE1-8A93518BC863Q30319871-E2DBB50F-8C7A-42D1-9345-64563E03FFB4Q33670304-3163359F-6417-48D0-8E23-A296FB6C166DQ33828978-E4504F9F-02BA-49CA-B8DE-462FC2764E30Q34227152-8AF6D48B-F755-4CA0-8598-025009EDEABEQ34334983-D96F47F8-B104-40F8-9BC3-80777F292E62Q34348367-26B43AC5-798C-4394-B574-8358645EBC86Q34380222-39D1021B-0208-42EE-8146-02623468EFB4Q35522107-260F32A6-B0B0-4D4B-BF8A-D7C399B02731Q35595960-7A17362A-EC5B-4616-95F9-394EEC4738F8Q35975150-7F86FC5C-3675-4611-A42B-9CFF20EFD8D8Q36012033-9F9FF17B-698C-4050-99E2-17D1DB17D95BQ36438737-1FF8AD93-62F7-4B2B-B2BF-F65B4B9571C7Q36720613-6536A55D-213C-44A6-A6DF-4CF43376F50AQ37190404-F3856EFE-C858-4541-8550-F01904833DC2Q37233353-2A115756-A0A9-45E1-8917-1E933BD927B5Q37600475-37E499FC-F639-4761-8EC4-E301C0BDFC43Q37708300-9D96B22D-8240-41BA-B617-4E07F61DA5ADQ37978926-DB290FE4-FC60-4CC9-8CBC-74EBC78433D7Q38289039-3664B9DB-8EAF-4F28-9A78-37E08CAA946EQ38461963-6E83E0E7-E6F2-414E-B31A-87101DEF0548Q40048144-4C5FBB1A-69E5-49B4-AA21-EDEEA9B173DAQ40758004-491E49B7-3608-424A-8F80-D7D940397846Q40773905-1BDB4BF2-D11B-45D4-834A-BD6E23CBCF53Q40797351-E54FA306-0479-4189-ADF8-3F22C593A0CFQ41814535-9A6D9EC6-4C39-4171-BC52-5AA456C087FFQ42048511-E3D67451-23D6-46C5-B03D-8AE5067DC51FQ42175960-8FEFCFA1-B88C-4467-9A88-6C34C50D6B7AQ42521078-085CD891-4D95-401D-A1B8-AC2CDAFB5984Q42777918-55460118-2A33-456E-AB9D-A456655B1DC8Q44158440-61A94066-3C7E-44D2-A5E4-91B6E6BC7DF4Q44177995-2361471F-4169-40B2-82B4-67F24B8A4BD7Q44568135-82F03EB2-0724-4FDE-9379-5FE5D71B41E9Q44756924-124475A2-8933-473F-A683-8E1F2E8F2ADBQ46571602-00CA1D4F-EE93-47D3-898B-5D6A251D243EQ46598346-A261A957-5BAE-43A8-8767-3439B8F77286Q47160173-549FE4DA-0F60-4C1F-8511-55F49930449FQ47944283-092B650A-9324-4B14-9673-22E2E92BBD58Q48070294-00DB473E-39F9-44E4-98BD-C42DB25B8DD9Q50040248-A6985AD1-DED7-441F-B2F1-140FA21F3263
P2860
Regulation of lipid and lipoprotein metabolism by PPAR activators.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Regulation of lipid and lipoprotein metabolism by PPAR activators.
@ast
Regulation of lipid and lipoprotein metabolism by PPAR activators.
@en
type
label
Regulation of lipid and lipoprotein metabolism by PPAR activators.
@ast
Regulation of lipid and lipoprotein metabolism by PPAR activators.
@en
prefLabel
Regulation of lipid and lipoprotein metabolism by PPAR activators.
@ast
Regulation of lipid and lipoprotein metabolism by PPAR activators.
@en
P2860
P356
P1476
Regulation of lipid and lipoprotein metabolism by PPAR activators.
@en
P2093
P2860
P356
10.1515/CCLM.2000.002
P577
2000-01-01T00:00:00Z